1. Home
  2. TYG vs AMPH Comparison

TYG vs AMPH Comparison

Compare TYG & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tortoise Energy Infrastructure Corporation

TYG

Tortoise Energy Infrastructure Corporation

HOLD

Current Price

$47.08

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$17.36

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYG
AMPH
Founded
2003
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
971.8M
IPO Year
2003
2005

Fundamental Metrics

Financial Performance
Metric
TYG
AMPH
Price
$47.08
$17.36
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$28.38
AVG Volume (30 Days)
124.4K
527.4K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
11.71%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
N/A
$6.90
Revenue Next Year
N/A
$4.64
P/E Ratio
$52.62
$130.64
Revenue Growth
N/A
N/A
52 Week Low
$39.93
$17.03
52 Week High
$51.18
$31.26

Technical Indicators

Market Signals
Indicator
TYG
AMPH
Relative Strength Index (RSI) 44.94 33.06
Support Level $46.51 $17.03
Resistance Level $50.87 $24.16
Average True Range (ATR) 1.01 0.84
MACD -0.29 -0.59
Stochastic Oscillator 39.75 1.48

Price Performance

Historical Comparison
TYG
AMPH

About TYG Tortoise Energy Infrastructure Corporation

Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: